Mutations in this key structural and functional element have been previously described in EGFR in non-small cell lung cancer, in BCR::ABL1 in CML, and in BRAF in colon cancer (60, 72, 73). This evidence concerns the gene BRAF and chronic myelogenous leukemia, BCR-ABL1 positive.